быстрая доставка ~4 недели
Размер
- 100 μg
- 1000 μg
- 500 μg
Recombinant Human VEGFR-2/KDR/CD309 Protein (RP02101)
- Описание
-
Overview
Product name Recombinant Human VEGFR-2/KDR/CD309 Protein Catalog No. RP02101 Description Recombinant Human KDR /VEGFR2 Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Ala20-Glu764) of Human KDR /VEGFR2 fused with a His and Avi tag at the C-terminal. Bio-Activity Immobilized Human VEGFR2, His Tag at 0.5 μg/ml (100 μL/Well). Dose response curve for Anti-VEGFR2 Ab. with the EC50 of 36.9 ng/mL determined by ELISA. Purity > 95% by Tris-Bis PAGE;> 95% by SEC-HPLC Endotoxin < 1 EU/μg of the protein by LAL method. Formulation Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. Species Human Product information
Synonym CD309 antigen; CD309; EC 2.7.10; EC 2.7.10.1; Fetal liver kinase 1; fetal liver kinase-1; Flk1; Flk-1; FLK1tyrosine kinase growth factor receptor; KDR; kinase insert domain receptor (a type III receptor tyrosine kinase); Kinase insert domain receptor; Pro Expression Host HEK293 cells Tag C-His&Avi Swiss-Prot Gene ID Usage guide
Storage Store the lyophilized protein at -20°C to -80°C for long term.
After reconstitution, the protein solution is stable at -20°C for 3 months, at 2-8°C for up to 1 week.Reconstitution Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. * For research use only. Not for therapeutic or diagnostic purposes.
Product Protocols